ProCE Banner Activity

CME

IL-17 Inhibition: A Targeted Approach to the Management of Psoriatic Arthritis

Multimedia
In this interactive, CME-certified video module, Dafna D. Gladman, MD, FRCPC, provides expert perspectives on approved and investigational IL-17–targeted therapies for treating psoriatic arthritis.

Physicians : maximum of 0.75 AMA PRA Category 1 {Credit}

Released: October 07, 2016

Expiration: January 07, 2018

No longer available for credit.

Share

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Lilly USA

Target Audience

This program is intended for rheumatologists, dermatologists, internists, family physicians, and other healthcare professionals caring for patients with psoriatic arthritis.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Explain the role of IL-17A in the pathogenesis of PsA and the mechanism of action of biologics targeting IL-17A.
  • Review new clinical trial data regarding the efficacies and safety profiles of biologics targeting IL-17A in the treatment of PsA and their expected role in clinical practice.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from October 07, 2016, through January 07, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve physicians’ knowledge and competence in selecting current and emerging treatment approaches for the management of patients with psoriatic arthritis.